Actigraphy; Activity Cycles/genetics; Adult; Age Factors; Body Weight; Catechol O-Methyltransferase/genetics; Dopamine Plasma Membrane Transport Proteins/genetics; Female; Gene Frequency; Healthy Volunteers; Heterozygote; Homozygote; Humans; Male; Minisatellite Repeats; Motor Activity/genetics; Phenotype; Polymorphism, Genetic; Sleep/genetics; Wakefulness/genetics; Young Adult; Body-mass-index; SLC6A3; circadian; daytime sleepiness; dopamine
Abstract :
[en] Accumulating evidence suggests that dopamine plays a key role in sleep-wake regulation. Cerebral dopamine levels are regulated primarily by the dopamine transporter (DAT) in the striatum and by catechol-O-methyl-transferase (COMT) in the prefrontal cortex. We hypothesized that the variable-number-tandem-repeat (VNTR) polymorphism in the 3'-untranslated region of the gene encoding DAT (DAT1, SLC6A3; rs28363170) and the Val158Met polymorphism of COMT (rs4680) differently affect actigraphy-derived rest-activity cycles and sleep estimates in healthy adults (65 men; 45 women; age range: 19-35 years). Daytime sleepiness, continuous rest-actigraphy and sleep diary data during roughly 4-weeks were analyzed. Nine-repeat (9R) allele carriers of DAT1 (n = 48) more often reported elevated sleepiness (Epworth sleepiness score >/=10) than 10-repeat (10R) allele homozygotes (n = 62, p < 0.02). Moreover, male 9R allele carriers showed higher wrist activity, whereas this difference was not present in women ("DAT1 genotype" x "gender" interaction: p < 0.005). Rest-activity patterns did not differ among COMT genotypes. Nevertheless, a significant "COMT genotype" x "type of day" (workdays vs. rest days) interaction for sleep duration was observed (p = 0.04). The Val/Val (n = 36) and Met/Met (n = 24) homozygotes habitually prolonged sleep on rest days compared to workdays by more than 30 min, while Val/Met heterozygotes (n = 50) did not significantly extend their sleep (mean difference: 7 min). Moreover, whereas the proportion of women among the genotype groups did not differ, COMT genotype affected body-mass-index (BMI), such that Val/Met individuals had lower BMI than the homozygous genotypes (p < 0.04). While awaiting independent replication and confirmation, our data support an association of genetically-determined differences in cerebral dopaminergic neurotransmission with daytime sleepiness and individual rest-activity profiles, as well as other sleep-associated health characteristics such as the regulation of BMI. The differential associations of DAT1 and COMT polymorphisms may reflect the distinct local expression of the encoded proteins in the brain.
Disciplines :
Neurosciences & behavior
Author, co-author :
Valomon, Amandine
Holst, Sebastian C.
Bachmann, Valerie
Viola, Antoine U.
Schmidt, Christina ; Université de Liège > Département de Psychologie : cognition et comportement > Neuropsychologie
Zurcher, Jurian
Berger, Wolfgang
Cajochen, Christian
Landolt, Hans-Peter
Language :
English
Title :
Genetic polymorphisms of DAT1 and COMT differentially associate with actigraphy-derived sleep-wake cycles in young adults.
Akil M, Kolachana BS, Rothmond DA, et al. (2003). Catechol-O- methyltransferase genotype and dopamine regulation in the human brain. J Neurosci. 23:2008-13. (Pubitemid 36368887)
Annerbrink K, Westberg L, Nilsson S, et al. (2008). Catechol O-methyltransferase val158-met polymorphism is associated with abdominal obesity and blood pressure in men. Metabolism. 57:708-11. (Pubitemid 351608233)
Barkley RA, Smith KM, Fischer M, Navia B. (2006). An examination of the behavioral and neuropsychological correlates of three ADHD candidate gene polymorphisms (DRD4 7+, DBH TaqI A2, and DAT1 40 bp VNTR) in hyperactive and normal children followed to adulthood. Am J Med Genet B Neuropsychiatr Genet. 141B:487-98. (Pubitemid 44024443)
Bodenmann S, Landolt HP. (2010). Effects of modafinil on the sleep EEG depend on Val158Met genotype of COMT. Sleep. 33: 1027-35.
Bodenmann S, Xu S, Luhmann UF, et al. (2009). Pharmacogenetics of modafinil after sleep loss: Catechol-O-methyltransferase genotype modulates waking functions but not recovery sleep. Clin Pharmacol Ther. 85:296-304.
Boonstra AM, Kooij JJ, Oosterlaan J, et al. (2007). Hyperactive night and day? Actigraphy studies in adult ADHD: A baseline comparison and the effect of methylphenidate. Sleep. 30: 433-42. (Pubitemid 46668700)
Borbely AA. (1982). A two process model of sleep regulation. Hum Neurobiol. 1:195-204. (Pubitemid 13213853)
Chen J, Lipska BK, Halim N, et al. (2004). Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): Effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet. 75:807-21. (Pubitemid 39390488)
Cheon KA, Ryu YH, Kim YK, et al. (2003). Dopamine transporter density in the basal ganglia assessed with [123I]IPT SPET in children with attention deficit hyperactivity disorder. Eur J Nucl Med Mol Imaging. 30:306-11. (Pubitemid 36686852)
Ciliax BJ, Heilman C, Demchyshyn LL, et al. (1995). The dopamine transporter: Immunochemical characterization and localization in brain. J Neurosci. 15:1714-23.
Cohen-Zion M, Ancoli-Israel S. (2004). Sleep in children with attention-deficit hyperactivity disorder (ADHD): A review of naturalistic and stimulant intervention studies. Sleep Med Rev. 8:379-402. (Pubitemid 39164487)
Cortese S, Faraone SV, Konofal E, Lecendreux M. (2009). Sleep in children with attention-deficit/hyperactivity disorder: Metaanalysis of subjective and objective studies. J Am Acad Child Adolesc Psychiatry. 48:894-908.
Costa A, Riedel M, Muller U, et al. (2011). Relationship between SLC6A3 genotype and striatal dopamine transporter availability: A meta-analysis of human single photon emission computed tomography studies. Synapse. 65:998-1005.
Dauvilliers Y, Neidhart E, Billiard M, Tafti M. (2002). Sexual dimorphism of the catechol-O-methyltransferase gene in narcolepsy is associated with response to modafinil. Pharmacogenomics J. 2:65-8. (Pubitemid 34982205)
Dauvilliers Y, Neidhart E, Lecendreux M, et al. (2001). MAO-A and COMT polymorphisms and gene effects in narcolepsy. Mol Psychiatry. 6:367-72. (Pubitemid 32566084)
Dougherty DD, Bonab AA, Spencer TJ, et al. (1999). Dopamine transporter density in patients with attention deficit hyperactivity disorder. Lancet. 354:2132-3. (Pubitemid 30008900)
Dreher JC, Schmidt PJ, Kohn P, et al. (2007). Menstrual cycle phase modulates reward-related neural function in women. Proc Natl Acad Sci USA. 104:2465-70. (Pubitemid 46391419)
Dresel S, Krause J, Krause KH, et al. (2000). Attention deficit hyperactivity disorder: Binding of [99mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment. Eur J Nucl Med. 27:1518-24.
Franke B, Vasquez AA, Johansson S, et al. (2010). Multicenter analysis of the SLC6A3/DAT1 VNTR haplotype in persistent ADHD suggests differential involvement of the gene in childhood and persistent ADHD. Neuropsychopharmacology. 35: 656-64.
Galvao AC, Kruger RC, Campagnolo PD, et al. (2012). Association of MAOA and COMT gene polymorphisms with palatable food intake in children. J Nutr Biochem. 23:272-7.
Giros B, Jaber M, Jones SR, et al. (1996). Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature. 379:606-12. (Pubitemid 26052818)
Gruber R, Grizenko N, Schwartz G, et al. (2006). Sleep and COMT polymorphism in ADHD children: Preliminary actigraphic data. J Am Acad Child Adolesc Psychiatry. 45:982-9. (Pubitemid 44126873)
Heinz A, Goldman D, Jones DW, et al. (2000). Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacology. 22:133-9. (Pubitemid 30016015)
Holst SC, Bersagliere A, Bachmann V, et al. (2014). Dopaminergic role in regulating neurophysiological markers of sleep homeostasis in humans. J Neurosci. 34:566-73.
Hosak L. (2007). Role of the COMT gene Val158Met polymorphism in mental disorders: A review. Eur Psychiatry. 22: 276-81. (Pubitemid 47088199)
Jacobsen LK, Staley JK, Zoghbi SS, et al. (2000). Prediction of dopamine transporter binding availability by genotype: A preliminary report. Am J Psychiatry. 157:1700-3.
Johns MW. (1991). A new method for measuring daytime sleepiness: The Epworth sleepiness scale. Sleep. 14:540-5.
Johns MW. (2000). Sensitivity and specificity of the multiple sleep latency test (MSLT), the maintenance of wakefulness test and the Epworth sleepiness scale: Failure of the MSLT as a gold standard. J Sleep Res. 9:5-11. (Pubitemid 30195287)
Kang AM, Palmatier MA, Kidd KK. (1999). Global variation of a 40-bp VNTR in the 30-untranslated region of the dopamine transporter gene (SLC6A3). Biol Psychiatry. 46:151-60. (Pubitemid 29320066)
Kereszturi E, Tarnok Z, Bognar E, et al. (2008). Catechol-O- methyltransferase Val158Met polymorphism is associated with methylphenidate response in ADHD children. Am J Med Genet B Neuropsychiatr Genet. 147B:1431-5.
Krause J, Dresel SH, Krause KH, et al. (2006). Striatal dopamine transporter availability and DAT-1 gene in adults with ADHD: No higher DAT availability in patients with homozygosity for the 10-repeat allele. World J Biol Psychiatry. 7:152-7. (Pubitemid 44132540)
Kume K, Kume S, Park SK, et al. (2005). Dopamine is a regulator of arousal in the fruit fly. J Neurosci. 25:7377-84. (Pubitemid 41129810)
Kurian MA, Zhen J, Cheng SY, et al. (2009). Homozygous lossof-function mutations in the gene encoding the dopamine transporter are associated with infantile Parkinsonism-Dystonia. J Clin Invest. 119:1595-603.
Lazar AS, Slak A, Lo JC, et al. (2012). Sleep, diurnal preference, health, and psychological well-being: A prospective singleallelic-variation study. Chronobiol Int. 29:131-46.
Lazarus M, Chen JF, Urade Y, Huang ZL. (2013). Role of the basal ganglia in the control of sleep and wakefulness. Curr Opin Neurobiol. 23:780-5.
Lu J, Jhou TC, Saper CB. (2006). Identification of wake-active dopaminergic neurons in the ventral periaqueductal gray matter. J Neurosci. 26:193-202. (Pubitemid 43089532)
Meyer-Lindenberg A, Kohn PD, Kolachana B, et al. (2005). Midbrain dopamine and prefrontal function in humans: Interaction and modulation by COMT genotype. Nat Neurosci. 8:594-96. (Pubitemid 40594200)
Michelhaugh SK, Fiskerstrand C, Lovejoy E, et al. (2001). The dopamine transporter gene (SLC6A3) variable number of tandem repeats domain enhances transcription in dopamine neurons. J Neurochem. 79:1033-8. (Pubitemid 33117083)
Miller GM, Madras BK. (2002). Polymorphisms in the 30-untranslated region of human and monkey dopamine transporter genes affect reporter gene expression. Mol Psychiatry. 7:44-55. (Pubitemid 34087878)
Minzenberg MJ. (2012). Pharmacotherapy for attention-deficit/ hyperactivity disorder: From cells to circuits. Neurotherapeutics. 9:610-21.
Monti JM, Monti D. (2007). The involvement of dopamine in the modulation of sleep and waking. Sleep Med Rev. 11:113-33. (Pubitemid 46330853)
Morgenthaler T, Alessi C, Friedman L, et al. (2007). Practice parameters for the use of actigraphy in the assessment of sleep and sleep disorders: An update for 2007. Sleep. 30:519-29. (Pubitemid 46668710)
Munro CA, McCaul ME, Wong DF, et al. (2006). Sex differences in striatal dopamine release in healthy adults. Biol Psychiatry. 59: 966-74.
Nakamura Y, Koyama K, Matsushima M. (1998). VNTR (variable number of tandem repeat) sequences as transcriptional, translational, or functional regulators. J Hum Genet. 43:149-52. (Pubitemid 128508722)
Need AC, Ahmadi KR, Spector TD, Goldstein DB. (2006). Obesity is associated with genetic variants that alter dopamine availability. Ann Hum Genet. 70:293-303.
Pico C, Puigserver P, Oliver P, Palou A. (1998). 2-Methoxyestradiol, an endogenous metabolite of 17beta-estradiol, inhibits adipocyte proliferation. Mol Cell Biochem. 189:1-7. (Pubitemid 28556541)
Portaluppi F, Smolensky MH, Touitou Y. (2010). Ethics and methods for biological rhythm research on animals and human beings. Chronobiol Int. 27:1911-29.
Qu WM, Xu XH, Yan MM, et al. (2010). Essential role of dopamine D2 receptor in the maintenance of wakefulness, but not in homeostatic regulation of sleep, in mice. J Neurosci. 30: 4382-9.
Roenneberg T, Allebrandt KV, Merrow M, Vetter C. (2012). Social jetlag and obesity. Curr Biol. 22:939-43.
Roenneberg T, Wirz-Justice A, Merrow M. (2003). Life between clocks: Daily temporal patterns of human chronotypes. J Biol Rhythms. 18:80-90. (Pubitemid 37187310)
Rousset F. (2008). genepop'007: A complete re-implementation of the genepop software for Windows and Linux. Mol Ecol Resour. 8:103-6. (Pubitemid 350231212)
Rye DB, Freeman AAH. (2011). Dopaminergic substrates underlying hypersomnia, sleepiness, and REM sleep expression. In: Baumann CR, Bassetti CL, Scammell TE, eds. Narcolepsy: Pathophysiology, diagnosis, and treatment. New York: Springer Science+Business Media, pp. 64-71.
Rye DB, Jankovic J. (2002). Emerging views of dopamine in modulating sleep/wake state from an unlikely source: PD. Neurology. 58:341-6. (Pubitemid 34150904)
Sadeh A. (2011). The role and validity of actigraphy in sleep medicine: An update. Sleep Med Rev. 15:259-67.
Schwartz MW, Woods SC, Porte Jr D, et al. (2000). Central nervous system control of food intake. Nature. 404:661-71. (Pubitemid 30205071)
Spencer TJ, Biederman J, Faraone SV, et al. (2013). Functional genomics of attention-deficit/hyperactivity disorder (ADHD) risk alleles on dopamine transporter binding in ADHD and healthy control subjects. Biol Psychiatry. 74:84-9.
Spencer TJ, Biederman J, Madras BK, et al. (2005). In vivo neuroreceptor imaging in attention-deficit/hyperactivity disorder: A focus on the dopamine transporter. Biol Psychiatry. 57: 1293-300. (Pubitemid 40798548)
Spiegel K, Tasali E, Leproult R, Van Cauter E. (2009). Effects of poor and short sleep on glucose metabolism and obesity risk. Nature Rev Endocrinol. 5:253-61.
Surman CB, Adamson JJ, Petty C, et al. (2009). Association between attention-deficit/hyperactivity disorder and sleep impairment in adulthood: Evidence from a large controlled study. J Clin Psychiatry. 70:1523-9.
Tonetti L, Pasquini F, Fabbri M, et al. (2008). Comparison of two different actigraphs with polysomnography in healthy young subjects. Chronobiol Int. 25:145-53. (Pubitemid 351300160)
Tunbridge EM, Harrison PJ, Weinberger DR. (2006). Catechol- omethyltransferase, cognition, and psychosis: Val158Met and beyond. Biol Psychiatry. 60:141-51.
Tworoger SS, Chubak J, Aiello EJ, et al. (2004). The effect of CYP19 and COMT polymorphisms on exercise-induced fat loss in postmenopausal women. Obes Res. 12:972-81. (Pubitemid 41202399)
Ueno T, Tomita J, Tanimoto H, et al. (2012). Identification of a dopamine pathway that regulates sleep and arousal in Drosophila. Nat Neurosci. 15:1516-23.
van de Giessen E, de Win MM, Tanck MW, et al. (2009). Striatal dopamine transporter availability associated with polymorphisms in the dopamine transporter gene SLC6A3. J Nucl Med. 50:45-52.
van Dyck CH, Malison RT, Jacobsen LK, et al. (2005). Increased dopamine transporter availability associated with the 9-repeat allele of the SLC6A3 gene. J Nucl Med. 46:745-51.
Van Someren EJ, Swaab DF, Colenda CC, et al. (1999). Bright light therapy: Improved sensitivity to its effects on rest-activity rhythms in Alzheimer patients by application of nonparametric methods. Chronobiol Int. 16:505-18. (Pubitemid 29362572)
Van Veen MM, Kooij JJ, Boonstra AM, et al. (2010). Delayed circadian rhythm in adults with attention-deficit/hyperactivity disorder and chronic sleep-onset insomnia. Biol Psychiatry. 67: 1091-6.
Vandenbergh DJ, Persico AM, Hawkins AL, et al. (1992). Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics. 14:1104-6. (Pubitemid 23053054)
Wang GJ, Volkow ND, Logan J, et al. (2001). Brain dopamine and obesity. Lancet. 357:354-7. (Pubitemid 32128542)
Whitehead DL, Davies AD, Playfer JR, Turnbull CJ. (2008). Circadian rest-activity rhythm is altered in Parkinson's disease patients with hallucinations. Mov Disord. 23:1137-45.
Wise RA, Bozarth MA. (1987). A psychomotor stimulant theory of addiction. Psychol Rev. 94:469-92.
Wisor JP, Nishino S, Sora I, et al. (2001). Dopaminergic role in stimulant-induced wakefulness. J Neurosci. 21: 1787-94. (Pubitemid 32184295)
